First Time Loading...

Amarin Corporation PLC
NASDAQ:AMRN

Watchlist Manager
Amarin Corporation PLC Logo
Amarin Corporation PLC
NASDAQ:AMRN
Watchlist
Price: 0.8393 USD -8.86% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

AMRN Price Targets Summary
Amarin Corporation PLC

Wall Street analysts forecast AMRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AMRN is 1.105 USD with a low forecast of 1.01 USD and a high forecast of 1.3125 USD.

AMRN Lowest Forecast
Wall Street Target
1.01 USD
20% Upside
AMRN Average Forecast
Wall Street Target
1.105 USD
32% Upside
AMRN Highest Forecast
Wall Street Target
1.3125 USD
56% Upside
Lowest
Price Target
1.01 USD
20% Upside
Average
Price Target
1.105 USD
32% Upside
Highest
Price Target
1.3125 USD
56% Upside
Amarin Corporation PLC Competitors:
Price Targets
603087
Gan & Lee Pharmaceuticals
22% Upside
RYTM
Rhythm Pharmaceuticals Inc
45% Upside
ALKS
Alkermes Plc
52% Upside
CDTX
Cidara Therapeutics Inc
55% Downside
603087
Gan & Lee Pharmaceuticals
22% Upside
RYTM
Rhythm Pharmaceuticals Inc
45% Upside
ALKS
Alkermes Plc
52% Upside
CDTX
Cidara Therapeutics Inc
55% Downside
87S
Roivant Sciences Ltd
48% Upside
PTCT
PTC Therapeutics Inc
17% Downside
PHARM
Pharming Group NV
112% Upside
CNTA
Centessa Pharmaceuticals PLC
46% Upside

Revenue
Forecast

Revenue Estimate
Amarin Corporation PLC

For the last 8 years the compound annual growth rate for Amarin Corporation PLC's revenue is 18%. The projected CAGR for the next 3 years is 0%.

18%
Past Growth
0%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amarin Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amarin Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
AMRN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMRN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMRN stock valuation using valuation multiples.
Wall Street Estimates
AMRN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMRN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMRN's stock price target?
Price Target
1.105 USD

According to Wall Street analysts, the average 1-year price target for AMRN is 1.105 USD with a low forecast of 1.01 USD and a high forecast of 1.3125 USD.

What is Amarin Corporation PLC's Revenue forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Amarin Corporation PLC's revenue is 18%. The projected CAGR for the next 3 years is 0%.

ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.